Sectors
RPRX
Royalty Pharma plc
58.18
1 x 58.08
1 x 58.24
bid
ask
+
0.21
0.35%
09:40 AM
timesize
| Ytd | 50.56% | |
| 1y | 60.75% |
57.93
day range
58.24
34.08
52 week range
60.44
| Open | 58.04 | Prev Close | 57.97 | Low | 57.93 | High | 58.24 | Mkt Cap | 25.78B |
| Vol | 60.76K | Avg Vol | 3.59M | EPS | 5.25 | P/E | 11.08 | Forward P/E | 9.99 |
| Beta | 0.43 | Short Ratio | 3.53 | Inst. Own | 85.63% | Dividend | 0.94 | Div Yield | 1.64 |
| Ex Div Date | 08-14 | Earning | 08-05 | 50-d Avg | 56.53 | 200-d Avg | 47.07 | 1yr Est | 63.75 |
| Income Statement | |||
| Total Revenue | 674.14M | ||
| Revenues (USD) | 674.14M | ||
| Gross Profit | 674.14M | ||
| Operating Expenses | 541.02M | ||
| Research and Development Expense | 97.85M | ||
| Selling, General and Administrative Expense | 161.89M | ||
| Operating Income | 133.12M | ||
| Interest Expense | 93.62M | ||
| Net Income | 17.88M | ||
| Net Income Common Stock | 17.88M | ||
| Net Income Common Stock (USD) | 17.88M | ||
| Consolidated Income | 81.49M | ||
| Net Income to Non-Controlling Interests | 63.60M | ||
| Earnings per Basic Share | 0.04 | ||
| Earnings per Basic Share (USD) | 0.04 | ||
| Earnings per Diluted Share | 0.04 | ||
| Dividends per Basic Common Share | 0.24 | ||
| Earning Before Interest & Taxes (EBIT) | 111.50M | ||
| Earning Before Interest & Taxes (USD) | 111.50M | ||
| Weighted Average Shares | 445.06M | ||
| Weighted Average Shares Diluted | 556.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 811.99M | ||
| Cash and Equivalents (USD) | 811.99M | ||
| Investments | 17.98B | ||
| Investments Current | 914.45M | ||
| Investments Non-Current | 17.07B | ||
| Trade and Non-Trade Receivables | 31.47M | ||
| Current Assets | 1.76B | ||
| Total Assets | 19.82B | ||
| Debt Current | 380.00M | ||
| Total Debt | 8.96B | ||
| Current Liabilities | 630.93M | ||
| Debt Non-Current | 8.58B | ||
| Total Liabilities | 10.03B | ||
| Accumulated Retained Earnings (Deficit) | 2.46B | ||
| Shareholders Equity | 9.79B | ||
| Shareholders Equity (USD) | 9.79B | ||
| Assets Non-Current | 18.06B | ||
| Total Debt (USD) | 8.96B | ||
| Goodwill and Intangible Assets | 923.54M | ||
| Liabilities Non-Current | 9.40B | ||
| Trade and Non-Trade Payables | 35.57M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -273.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 225.59M | ||
| Issuance (Purchase) of Equity Shares | -44.64M | ||
| Issuance (Repayment) of Debt Securities | -2.46M | ||
| Payment of Dividends & Other Cash Distributions | -104.92M | ||
| Net Cash Flow from Investing | -229.72M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -229.40M | ||
| Net Cash Flow from Operations | 728.46M | ||